• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS One . Haemostatic differences between SARS-CoV-2 PCR-positive and negative patients at the time of hospital admission

tetano

Editor, Senior Moderator
PLoS One


. 2022 Apr 28;17(4):e0267605.
doi: 10.1371/journal.pone.0267605. eCollection 2022.
Haemostatic differences between SARS-CoV-2 PCR-positive and negative patients at the time of hospital admission


B de Laat[SUP] 1 [/SUP], M J M Traets[SUP] 2 [/SUP], R W M De Laat-Kremers[SUP] 1 [/SUP], S P Verweij[SUP] 2 [/SUP], M Ninivaggi[SUP] 1 [/SUP], E Jong[SUP] 2 [/SUP], D Huskens[SUP] 1 [/SUP], B A Blok[SUP] 2 [/SUP], G C P Remme[SUP] 2 [/SUP], A Miszta[SUP] 1 [/SUP], R H T Nijhuis[SUP] 3 [/SUP], G J M Herder[SUP] 4 [/SUP], R Fijnheer[SUP] 2 [/SUP], M Roest[SUP] 1 [/SUP], A T L Fiolet[SUP] 2 [/SUP], J A Remijn[SUP] 5 [/SUP]



Affiliations

Abstract

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is associated with thrombosis. We conducted a cohort study of consecutive patients, suspected of SARS-CoV-2 infection presented to the emergency department. We investigated haemostatic differences between SARS-CoV-2 PCR positive and negative patients, with dedicated coagulation analysis. The 519 included patients had a median age of 66 years, and 52.5% of the patients were male. Twenty-six percent of the patients were PCR-positive for SARS-CoV-2.PCR positive patients had increased levels of fibrinogen and (active) von Willebrand Factor (VWF) and decreased levels of protein C and α2-macroglobulin compared to the PCR negative patients. In addition, we found acquired activated protein C resistance in PCR positive patients. Furthermore, we found that elevated levels of factor VIII and VWF and decreased levels of ADAMTS-13 were associated with an increased incidence of thrombosis in PCR positive patients. In conclusion, we found that PCR positive patients had a pronounced prothrombotic phenotype, mainly due to an increase of endothelial activation upon admission to the hospital. These findings show that coagulation tests may be considered useful to discriminate severe cases of COVID-19 at risk for thrombosis.
 
Back
Top Bottom